Financial Performance - Total revenues decreased 3.1% to $686.5 million in Q2 FY2025 compared to $708.4 million in Q2 FY2024[4] - Net income for Q2 FY2025 was $19.7 million, or $2.43 per diluted share, compared to $50.8 million, or $6.66 per diluted share in Q2 FY2024[6] - Adjusted EBITDA for the three months ended April 30, 2025, was $61.3 million, compared to $102.2 million for the same period in 2024, reflecting a decrease of 40.1%[29] - The net income available to common stockholders for the three months ended April 30, 2025, was $17,057,000, a decline of 64.6% from $48,167,000 in 2024[42] - Income before income taxes for the three months ended April 30, 2025, was $26,530,000, a significant decrease of 61.8% compared to $69,392,000 in 2024[42] Homebuilding Metrics - Homebuilding gross margin percentage after cost of sales was 13.8% in Q2 FY2025, down from 19.5% in Q2 FY2024[4] - Consolidated contracts decreased 7.5% to 1,398 homes valued at $706.6 million in Q2 FY2025 compared to 1,512 homes valued at $785.8 million in Q2 FY2024[6] - Home deliveries totaled 1,398 units for the three months ended April 30, 2025, a decrease of 7.5% from 1,512 units in 2024[44] - Total home deliveries decreased by 1.4% to 2,603 homes compared to 2,639 homes in the previous year[49] - The backlog of contracts as of April 30, 2025, was 1,711 homes, reflecting a decrease of 15.2% from 2,018 homes in 2024[44] Liquidity and Financial Position - Total liquidity as of April 30, 2025, was $202.4 million, within the targeted range of $170 million to $245 million[13] - Cash and cash equivalents decreased to $73,980,000 as of April 30, 2025, from $209,976,000 as of October 31, 2024[40] - The company reported a total liabilities figure of $1,732,729,000 as of April 30, 2025, down from $1,805,225,000 in the previous period[40] - The company’s total stockholders' equity increased to $820,370,000 as of April 30, 2025, compared to $800,349,000 as of October 31, 2024[40] Future Outlook - The company expects total revenues for Q3 FY2025 to be between $750 million and $850 million[9] - Adjusted homebuilding gross margin for Q3 FY2025 is expected to be between 17.0% and 18.0%[9] - Forward-looking statements indicate potential risks including economic conditions, interest rate fluctuations, and supply chain issues that may impact future performance[23] Inventory and Assets - Total inventories increased to $1,743,965,000 as of April 30, 2025, compared to $1,644,804,000 as of October 31, 2024, reflecting a growth of approximately 6%[40] - Total assets decreased to $2,553,099,000 as of April 30, 2025, from $2,605,574,000 as of October 31, 2024[40] Segment Performance - The Northeast segment saw a 10.8% decrease in revenue to $513,432 thousand, while home deliveries increased by 35.0% to 895 homes[49] - The Southeast segment experienced a 12.1% increase in revenue to $159,970 thousand, with home deliveries rising by 10.9% to 304 homes[49] - The West segment reported a 2.2% decrease in revenue to $676,484 thousand, with home deliveries declining by 5.0% to 1,362 homes[49] Joint Ventures - Income from unconsolidated joint ventures for the three months ended April 30, 2025, was $9.0 million, down 19.0% from $11.2 million in the same period of 2024[25] - The company reports its proportionate share of income or loss from unconsolidated homebuilding and land development joint ventures as a separate line item in consolidated financial statements[61] - Overall, the unconsolidated joint ventures (excluding KSA JV) reported a 7.2% decrease in home deliveries to 231 units, with contract dollars down by 14.8% to $149.5 million[58]

Financial Performance - Total revenues decreased 3.1% to $686.5 million in Q2 FY2025 compared to $708.4 million in Q2 FY2024, while total revenues for the first half increased 4.4% to $1.36 billion[4]. - Net income for Q2 FY2025 was $19.7 million, or $2.43 per diluted common share, compared to $50.8 million, or $6.66 per diluted common share in Q2 FY2024[6]. - Adjusted EBITDA for the three months ended April 30, 2025, was $61.3 million, a decrease from $102.2 million in the same period of 2024[29]. - Income before income taxes for the three months ended April 30, 2025, was $26,530,000, a significant decrease of 61.8% compared to $69,392,000 in 2024[42]. - The net income available to common stockholders for the three months ended April 30, 2025, was $17,057,000, a decline of 64.6% from $48,167,000 in the same period of 2024[42]. Homebuilding Metrics - Homebuilding gross margin percentage after cost of sales interest expense and land charges was 13.8% in Q2 FY2025, down from 19.5% in Q2 FY2024[4]. - Consolidated contracts decreased 7.5% to 1,398 homes valued at $706.6 million in Q2 FY2025 compared to 1,512 homes valued at $785.8 million in Q2 FY2024[6]. - Home deliveries for the three months ended April 30, 2025, totaled 1,398 units, a decrease of 7.5% from 1,512 units in 2024[44]. - Total home deliveries decreased by 1.4% to 2,603 homes compared to 2,639 homes in the previous year[49]. - The company’s backlog as of April 30, 2025, was 1,711 homes, reflecting a decrease of 15.2% from 2,018 homes in 2024[44]. Revenue and Sales Trends - Home sales revenue decreased to $650,314,000 for the three months ended April 30, 2025, down 5.3% from $686,929,000 in 2024[42]. - Consolidated total revenue from home sales was $1,349,886 thousand, a decline of 4.3% from $1,410,162 thousand[49]. - The average price of homes sold decreased by 3.7% to $525,535 for the three months ended April 30, 2025, compared to $545,825 in 2024[44]. - The average price of homes in the West region increased by 2.3% to $492,431 for the three months ended April 30, 2025, compared to $481,569 in 2024[44]. - The average home price decreased by 3.0% to $518,589 thousand from $534,355 thousand[49]. Liquidity and Financial Position - Total liquidity as of April 30, 2025, was $202.4 million, within the targeted range of $170 million to $245 million[13]. - Cash and cash equivalents decreased to $73,980,000 from $209,976,000 as of October 31, 2024, a decline of approximately 64.7%[40]. - Total assets decreased to $2,553,099,000 as of April 30, 2025, from $2,605,574,000 as of October 31, 2024, a reduction of approximately 2.0%[40]. - The total liabilities decreased to $1,732,729,000 as of April 30, 2025, from $1,805,225,000 as of October 31, 2024, reflecting a decrease of about 4.0%[40]. Future Outlook and Strategic Initiatives - The company expects total revenues for Q3 FY2025 to be between $750 million and $850 million, with adjusted homebuilding gross margin between 17.0% and 18.0%[9]. - The company anticipates challenges due to economic conditions, including inflation and supply chain issues, which may impact future performance[23]. - Future outlook includes continued focus on joint ventures and market expansion strategies to enhance revenue growth[49]. Joint Ventures and Segment Performance - Income from unconsolidated joint ventures for the three months ended April 30, 2025, was $9.0 million, down from $11.2 million in the same period of 2024[25]. - The KSA joint venture reported a significant increase in home deliveries to 293 homes, up 196.0%, with revenue rising to $74,932 thousand, a 252.8% increase[49]. - Overall, the unconsolidated joint ventures (excluding KSA JV) reported a 7.2% decrease in home deliveries to 231 homes, with contract dollars down 14.8% to $149.5 million[58]. - The company reclassified 86 homes and $70.1 million of contract backlog from the Northeast segment to unconsolidated joint ventures, indicating strategic adjustments in asset management[56].

Business Segments - FOXO Technologies Inc. operates in two reportable business segments: Healthcare and Labs and Life, with a focus on behavioral health services and epigenetic diagnostics [205]. - The company finalized the acquisition of Myrtle and RCHI in 2024, expecting these businesses to produce a small cash flow surplus through 2025 [261]. Acquisitions - The company completed the acquisition of Myrtle for $0.5 million, which included a $0.3 million non-interest bearing note payable and 102,363 shares of Class A Common Stock [211]. - The company acquired RCHI and its subsidiary SCCH, with a senior secured note issued for $22.0 million, maturing on September 10, 2026, and accruing interest at rates of 8% to 20% [216][217]. - Myrtle's alcohol and drug treatment facility began operations on August 14, 2023, offering services for up to 30 patients, and expanded to include a Nonresidential Office-Based Opiate Treatment Facility on November 1, 2023 [213][224]. - The company plans to expand Myrtle's business model by acquiring additional facilities and replicating the model in other rural areas [224]. Financial Performance - Net revenues for the three months ended March 31, 2025, were $3.2 million, a significant increase from $7,180 for the same period in 2024, with contributions of $0.5 million from Myrtle and $2.7 million from RCHI [234]. - Direct costs of revenues were $1.9 million for the three months ended March 31, 2025, with no direct costs reported for the same period in 2024, attributed to the acquisitions of Myrtle and RCHI [235]. - Research and development expenses decreased to $30,000 for the three months ended March 31, 2025, from $165,360 in the same period of 2024, reflecting the cessation of ongoing projects [236]. - Selling, general and administrative expenses rose to $2.8 million for the three months ended March 31, 2025, compared to $1.0 million in 2024, primarily due to expenses from the acquired companies [238]. - The net loss attributable to FOXO was $0.6 million for the three months ended March 31, 2025, an improvement from a loss of $1.5 million in 2024, mainly due to a gain from extinguishment of Senior PIK Notes [243]. - The company recorded a gain of $1.9 million from the extinguishment of $5.4 million of Senior PIK Notes during the three months ended March 31, 2025 [240]. - Total revenues for the healthcare segment were $3.2 million for the three months ended March 31, 2025, with a segment loss of $0.8 million [245]. - Labs and Life segment revenues increased by 18.23% to $8,489 for the three months ended March 31, 2025, compared to $7,180 in 2024 [248]. Cash Flow and Capital - As of March 31, 2025, the company had cash and cash equivalents of $16,907, a decrease of $51,361 from $68,268 as of December 31, 2024 [266]. - For the three months ended March 31, 2025, the company incurred a net loss of $1.1 million, an improvement from a net loss of $2.2 million for the same period in 2024 [250]. - The working capital deficit improved to $25.5 million as of March 31, 2025, compared to $29.8 million as of December 31, 2024, reflecting a change of $4.4 million [266]. - Total debt, net of discounts, decreased to $6.0 million as of March 31, 2025, down from $10.2 million as of December 31, 2024, a reduction of $4.2 million [266]. - Net cash used in operating activities for the three months ended March 31, 2025, was $1.3 million, compared to $0.4 million for the same period in 2024, indicating an increase in cash used by $0.9 million [268]. - The company raised $1.3 million from financing activities during the three months ended March 31, 2025, compared to $0.4 million in the same period of 2024 [270]. - The company expects to incur additional losses in future periods and requires additional capital to fund its operations [250]. Revenue Recognition and Accounting - Estimated contractual allowances and implicit price concessions of $17.5 million were recorded as reductions to revenues for the three months ended March 31, 2025 [283]. - After accounting for estimated contractual allowances and implicit price concessions, the healthcare segment recorded net revenues of $3.2 million for the three months ended March 31, 2025 [283]. - The healthcare segment's primary source of operating cash is the collection of outstanding receivables, which is critical to its operating performance [281]. - The performance obligations for inpatient services are generally satisfied over periods averaging approximately 7 to 28 days, while outpatient services are satisfied in less than one day [278]. - The healthcare segment's revenues are based on estimated amounts expected to be received from third-party payers and patients, influenced by Medicare and Medicaid rates [279]. - The company does not present "allowances for doubtful accounts" on its balance sheets; accounts receivable are reported at realizable value, net of estimated contractual allowances [282]. - The company assesses going concern uncertainty quarterly, considering cash and working capital to operate for at least one year from the issuance date of consolidated financial statements [286]. Future Plans and Developments - The company entered into a KR8 Agreement to develop a Direct-to-Consumer APP utilizing AI Machine Learning technology, effective January 12, 2024 [231]. - The company plans to adopt ASU 2023-09 effective January 1, 2025, which requires enhanced annual disclosures for specific categories in income tax disclosures [287].

Financial Performance - Gross margin percentage increased by 1.8% year-over-year to 9.8% in 2024 from 7.9% in 2023 due to more profitable routes and operational efficiency improvements[7] - Cash flow from operations improved by $1.6 million year-over-year to -$4.2 million from -$5.8 million in 2023, driven by better margins and working capital management[7] - Net loss improved by $3.7 million year-over-year to -$5.6 million in 2024 from -$9.3 million in 2023, despite lower revenue, due to higher gross margins and lower operating expenses[7] - Revenue for 2024 was reported at $13.73 million, down from $17.06 million in 2023[11] - Net loss for 2024 was $5,601,227, an improvement from a net loss of $9,327,606 in 2023, representing a reduction of approximately 40%[17] Assets and Liabilities - Total assets decreased to $5.69 million in 2024 from $10.04 million in 2023[13] - Total liabilities decreased to $6.35 million in 2024 from $7.41 million in 2023[13] Cash Flow and Financing - Cash used in operating activities decreased to $4,206,168 in 2024 from $5,790,684 in 2023, indicating a 27% improvement[17] - Cash and cash equivalents at the end of the period dropped to $204,032 from $1,560,105, reflecting a decrease of approximately 87%[17] - Net cash provided by financing activities was $4,242,023 in 2024, down from $6,800,722 in 2023, a decline of about 38%[17] - The company reported a gain from extinguishment of debt amounting to $1,607,766 in 2024[17] - Proceeds from issuance of common stock from ATM Offering amounted to $3,079,016 in 2024[17] Operational Highlights - Fr8Fleet, the dedicated capacity service, achieved 42% year-over-year revenue growth[3] - The company launched Waavely, an ocean freight booking and management platform, in July 2024, and Fleet Rocket, a Transportation Management System, in February 2025[2][3] - Customer satisfaction survey indicated a response rate of over 80%, with average scores greater than four out of five[3] - The company expects to continue improving financial results in 2025, focusing on software offerings and AI-powered solutions[5] Expenses and Costs - Depreciation and amortization increased to $430,414 in 2024 from $404,598 in 2023, a rise of about 6%[17] - Share-based compensation decreased to $981,023 in 2024 from $1,153,787 in 2023, a reduction of approximately 15%[17] - Accounts receivable increased significantly to $1,120,176 in 2024 from $45,383 in 2023, indicating a substantial growth[17] - The company capitalized software development costs of $336,153 in 2024, slightly up from $328,645 in 2023[17]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Form 20-F ý Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): SAFE BULKERS, INC. (Tran ...

Financial Performance - The Company recorded a net loss of $89,624 for the three months ended March 31, 2025, consisting of operating costs of $355,862 and interest expense of $1,125, partially offset by investment income of $267,363[137]. - The Company recorded a net income of $357,077 for the three months ended March 31, 2024, primarily from investment income of $735,578[138]. - The Company has not generated any revenues to date and will only generate non-operating income after the completion of its Business Combination[136]. - Interest expenses under the promissory note to third parties were recorded at $1,125 for the three months ended March 31, 2025[147]. Cash and Working Capital - As of March 31, 2025, the Company had cash of $17,229 and a working capital deficit of $3,214,910[139]. - The Company borrowed $241,112 under Working Capital Loans as of March 31, 2025, which are included in convertible promissory notes[141]. - The Company borrowed a total of $841,112 from the Chief Financial Officer in the form of convertible promissory notes, which are repayable upon the consummation of the Business Combination[143]. - The CFO also paid $144,060 to third-party vendors for working capital purposes, which are unsecured and due on demand[144]. - From July 2024 to March 2025, the Company borrowed a total of $975,000 from Tianji and its subsidiaries, with an additional $100,000 received after March 31, 2025, bringing the total to $1,075,000 due to third parties[145]. Business Combination and Acquisition Plans - The Company entered into a merger agreement on January 26, 2025, with Tianji Tire Global (Cayman) Limited, involving a total merger consideration of $450,000,000[131][133]. - The Company has incurred significant costs in pursuit of its acquisition plans and cannot assure the success of completing a Business Combination[116]. - The Company has incurred significant costs related to financing and acquisition plans, raising concerns about its ability to continue as a going concern if the Initial Business Combination is not completed by August 12, 2025[148]. - The Company has the right to extend the Termination Date of its Business Combination up to ten additional times by depositing $75,000 per month, with a current outstanding requirement of $600,000 for extensions[120]. Compliance and Regulatory Matters - The Company received a delisting determination letter from Nasdaq on April 23, 2024, but subsequently paid the outstanding fee to regain compliance[121]. - There are no off-balance sheet arrangements or long-term liabilities as of March 31, 2025[149][150]. - The underwriter is entitled to a deferred fee of $2,587,499, which will be revised to $750,000 in cash and 200,000 shares upon the closing of the Business Combination[150]. Management and Operations - Management does not anticipate any material effects from recently issued accounting pronouncements on the financial statements[152]. - The Company has conducted no operations to date, resulting in no unaudited quarterly operating data being included in the report[153].

Financial Performance - The Company recorded a net loss of $89,624 for the three months ended March 31, 2025, consisting of operating costs of $355,862 and interest expense of $1,125, partially offset by investment income of $267,363 [137]. - For the three months ended March 31, 2024, the Company had a net income of $357,077, primarily from investment income of $735,578, offset by operating costs of $49,800 and a loss on modification of deferred underwriter commission of $378,501 [138]. Cash and Working Capital - As of March 31, 2025, the Company had cash of $17,229 and a working capital deficit of $3,214,910 [139]. Borrowings and Debt - The Company has borrowed $775,000 from a subsidiary of Tianji from July 2024 to December 2024, and an additional $300,000 from Tianji and its subsidiaries from January 2025 to April 2025, all of which are unsecured and non-interest bearing [128]. - The Company borrowed a total of $841,112 from the Chief Financial Officer in the form of convertible promissory notes, which are repayable upon the consummation of the Business Combination [143]. - The CFO also paid $144,060 to third-party vendors for working capital, which is due on demand [144]. - From July 2024 to March 2025, the Company borrowed a total of $975,000 from Tianji and its subsidiaries, with an additional $100,000 received after March 31, 2025, bringing the total due to third parties to $1,075,000 [145]. - The Company issued a promissory note for $300,000 with an annual interest rate of 9.127%, of which $50,000 remained unpaid as of March 31, 2025 [146]. - Interest expenses under the promissory note for the three months ended March 31, 2025, were recorded at $1,125, with total outstanding amounts of $55,789 [147]. Acquisition Plans - The Company entered into a merger agreement on January 26, 2025, with Tianji Tire Global (Cayman) Limited, involving a total merger consideration of $450,000,000 [131][133]. - The Company has incurred significant costs in pursuit of its acquisition plans and cannot assure the success of completing a Business Combination [116]. - The Company has incurred significant costs related to financing and acquisition plans, raising concerns about its ability to continue as a going concern if the Initial Business Combination is not completed by August 12, 2025 [148]. Shareholder Actions - 2,903,151 ordinary shares were tendered for redemption during the extraordinary general meeting on August 12, 2024, leaving 2,224,131 ordinary shares still subject to redemption [119]. Financial Obligations - The underwriter is entitled to a deferred fee of $2,587,499, which will be revised to $750,000 in cash and 200,000 shares upon the closing of the Business Combination [150]. Accounting and Estimates - As of March 31, 2025, there were no critical accounting estimates affecting the financial statements [151]. - Management does not anticipate that any recently issued accounting pronouncements will materially affect the Company's financial statements [152]. Business Combination Timeline - The Company has the right to extend the Termination Date of its Business Combination up to ten additional times by depositing $75,000 per month, with the current Termination Date extended to October 12, 2024 [120]. - At the effective time of the Acquisition Merger, each Tianji Class A ordinary share will be converted into the right to receive one Reincorporation Merger Surviving Corporation Class A ordinary share [132]. Off-Balance Sheet Arrangements - There are no off-balance sheet arrangements or long-term liabilities as of March 31, 2025 [149].

Financial Performance - For Q1 2025, net revenue was $1.4 million, down from $2.4 million in Q1 2024, primarily due to a $1.0 million decrease in consumer products revenue[18]. - Revenues for the three months ended March 31, 2025, were $1,431 million, down 39.2% from $2,356 million for the same period in 2024[32]. - The company reported a net income of $3,966 million for the three months ended March 31, 2025, compared to a net loss of $6,265 million in the same period of 2024[32]. - Net loss from continuing operations for Q1 2025 was $4.7 million, or $(0.13) per share, compared to a net loss of $5.5 million, or $(0.32) per share, in Q1 2024[23]. - Adjusted EBITDA from continuing operations improved to a loss of $1,614 million for Q1 2025, compared to a loss of $4,286 million in Q1 2024[40]. Cost Management - General and administration expenses decreased to $4.1 million in Q1 2025 from $7.3 million in Q1 2024, reflecting a reduction of $3.2 million[21]. - Research and development costs were $97,000 in Q1 2025, down from $272,000 in Q1 2024, a decrease of $175,000[22]. - The company has significantly reduced its workforce from 96 employees in December 2024 to 25 full-time employees currently, aiming to streamline operations and reduce overhead costs[4]. Asset and Equity Changes - Total stockholders' equity increased to $15.1 million as of March 31, 2025, up from $7.4 million at December 31, 2024[24]. - Total assets decreased from $63,200 million as of December 31, 2024, to $50,111 million as of March 31, 2025, representing a decline of approximately 20.7%[30]. - Total current liabilities decreased from $32,134 million as of December 31, 2024, to $24,052 million as of March 31, 2025, a reduction of about 25.3%[30]. Cash Flow and Debt - Cash and cash equivalents decreased from $1,175 million at the end of Q1 2024 to $88 million at the end of Q1 2025, a decline of approximately 92.5%[34]. - The company incurred a debt extinguishment loss of $431 million in Q1 2025, which was not present in Q1 2024[32]. - The company reported cash paid for income taxes of $256 million in Q1 2025, compared to $318 million in Q1 2024, indicating a decrease of approximately 19.5%[35]. Future Prospects - The company anticipates a potential recovery of approximately $50 million in insurance payments through Crown Medical Collections, which could provide significant cash flow in the second half of 2025[9][10]. - ProPhase is pursuing the sale of its subsidiary Nebula Genomics, with expectations of receiving letters of intent in the coming weeks and a potential sale within 3-4 months[7]. - The BE-Smart Esophageal Cancer Test is nearing commercialization, with a recent submission for peer review highlighting its potential to improve clinical testing for esophageal disease[11][13]. Profitability Metrics - Gross margin profit for Q1 2025 was $0.5 million, compared to a gross margin loss of $0.1 million in Q1 2024, resulting in an overall gross margin of 36.8% versus (2.5)%[20]. - Gross profit for the first quarter of 2025 was $526 million, compared to a gross loss of $60 million in the same quarter of 2024, indicating a significant improvement[32]. - Weighted average common shares outstanding increased from 17,207 million in Q1 2024 to 35,233 million in Q1 2025, reflecting a significant increase in share issuance[32].

Financial Performance - Total net revenues for Q1 2025 were RMB947.1 million (US$130.5 million), a decrease of 8.9% from RMB1,039.7 million in Q1 2024[5] - Gross profit increased by 4.1% to RMB113.5 million (US$15.6 million), with a gross margin of 12.0%, up from 10.5% in the same period last year[17] - Loss from operations was reduced by 84.3% to RMB26.1 million (US$3.6 million) compared to RMB166.9 million in Q1 2024[19] - Net loss decreased by 9.5% to RMB79.6 million (US$11.0 million) from RMB88.0 million in the same period last year[20] - Adjusted net loss (non-GAAP) was RMB20.9 million (US$2.9 million), down 75.6% from RMB85.7 million in Q1 2024[20] User Engagement - Average mobile MAUs were 41.4 million, down 8.7% year-over-year, attributed to fewer official tournament broadcasts[15] - Livestreaming revenues decreased by 29.5% to RMB564.5 million (US$77.8 million) due to a decline in paying users and average revenue per paying user[8] Revenue Streams - Revenues from innovative business, advertising, and others increased by 60.2% to RMB382.6 million (US$52.7 million), driven by voice-based social networking and game membership services[9] Cash and Assets - Cash and cash equivalents as of March 31, 2025, were RMB2,308.8 million (US$318.2 million), down from RMB4,467.8 million as of December 31, 2024, primarily due to a US$300 million special cash dividend[22] - As of March 31, 2025, total assets amounted to RMB 3,202,082, a decrease from RMB 5,446,333 as of December 31, 2024[31] - Cash and cash equivalents increased to RMB 1,852,492 as of March 31, 2025, from RMB 1,017,148 as of December 31, 2024[31] Expenses - Research and development expenses decreased by 39.5% to RMB32.7 million (US$4.5 million) from RMB54.2 million in Q1 2024, mainly due to reduced staff-related expenses[18] - Research and development expenses for the three months ended March 31, 2025, were RMB 32,749, down from RMB 54,150 in the same period of 2024[33] Shareholder Equity - The company’s accumulated deficit as of March 31, 2025, was RMB (3,871,429), an increase from RMB (3,791,817) as of December 31, 2024[32] - The total shareholders' equity as of March 31, 2025, was RMB 1,971,651, a significant decrease from RMB 4,210,089 as of December 31, 2024[32]

Financial Performance - Record annual revenue of $2.3 billion, up slightly from the prior year[4] - Net earnings of $463.4 million, down 3%, with record net earnings per diluted share of $13.77, up 1%[4] - Adjusted EBITDA of $816.7 million, down 2%[4] - Fourth quarter revenue of $470.2 million, down 1%, with net earnings of $66.5 million, down 14%[4] - Fiscal 2025 revenue in the Heavy Materials sector down 2% to $1.4 billion, with operating earnings decreasing 11% to $310.7 million[9] - Fiscal 2025 revenue in the Light Materials sector increased 3% to $969.2 million, driven by higher sales volume and prices[16] - Total revenue for the quarter ended March 31, 2025, was $470.175 million, a decrease of 1.1% from $476.707 million in the same quarter of 2024[30] - Net earnings for the quarter were $66.480 million, down 13.7% from $77.099 million year-over-year[30] - The company reported a gross profit of $104.612 million for the quarter, compared to $119.680 million in the prior year, reflecting a decrease of 12.6%[30] - The total revenue for the fiscal year ended March 31, 2025, was $2.260 billion, slightly up from $2.259 billion in the previous fiscal year[30] - Adjusted EBITDA for the fiscal year ended March 31, 2025, was $816,674,000, down from $834,494,000 in 2024, a decrease of 2.1%[41] Investments and Acquisitions - Completed acquisitions of two aggregates businesses for a combined investment of $175 million[6] - Announced a $330 million investment to modernize and expand the Duke, OK Gypsum Wallboard plant, expected to increase capacity by 300 million square feet (25%)[6] Expenses and Costs - Corporate General and Administrative Expenses increased by approximately 24% due to higher IT spending and acquisition-related costs[20] - The company’s corporate general and administrative expenses increased to $19.596 million for the quarter, compared to $17.339 million in the same quarter of 2024[32] - The company incurred $3,359,000 in acquisition accounting and related expenses for the quarter ended March 31, 2025[40] Debt and Leverage - Maintained a net leverage ratio of 1.5x, ending the year with debt of $1.2 billion[5] - Total debt, excluding debt issuance costs, rose to $1,246,250,000 in 2025 from $1,102,500,000 in 2024, an increase of 13.1%[43] - Net Debt to Adjusted EBITDA ratio increased to 1.5x in 2025 from 1.3x in 2024, indicating a higher leverage position[43] Sales and Pricing - The average net sales price for cement increased by 2% to $157.62 per ton compared to $154.59 per ton in the previous year[34] - Cement sales volume decreased by 5% to 1.081 million tons for the quarter, while the total sales volume for the fiscal year decreased by 6% to 6.237 million tons[34] - Revenue from recycled paperboard increased by 9% year-over-year to $604.02 per ton for the fiscal year ended March 31, 2025[34] Assets and Equity - Total current assets increased to $668,657,000 in 2025 from $627,693,000 in 2024, representing a growth of 6.5%[36] - The company reported a total stockholders' equity of $1,456,700,000 in 2025, up from $1,308,535,000 in 2024, an increase of 11.3%[36] Cash Flow - Cash and cash equivalents decreased to $20,401,000 in 2025 from $34,925,000 in 2024, a decline of 41.5%[43] Depreciation and Amortization - Depreciation, depletion, and amortization for the quarter ended March 31, 2025, totaled $42,241,000, an increase from $38,485,000 in 2024, reflecting a rise of 9.2%[38] Interest Expense - The company’s interest expense for the fiscal year was $40.526 million, down from $42.257 million in the previous year[30] Earnings Per Share - Adjusted net earnings per diluted share (Adjusted EPS) for the fiscal year ended March 31, 2025, was $13.94, slightly up from $13.71 in 2024, an increase of 1.7%[40]